| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/06/2013 | US20130143268 Method of producing the polypeptide for treating virus-induced cancer |
| 06/06/2013 | US20130143265 Zcytor17 heterodimeric cytokine receptor polynucleotides |
| 06/06/2013 | US20130142867 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 06/06/2013 | US20130142865 Fixed dosing of her antibodies |
| 06/06/2013 | US20130142864 In vivo targeting of dendritic cells |
| 06/06/2013 | US20130142836 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent |
| 06/06/2013 | US20130142819 Leishmanicidal formulation and its use |
| 06/06/2013 | US20130142816 Compositions and methods for enhancing fertility |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | US20130142797 Method of treating virus-induced cancer |
| 06/06/2013 | US20130142784 Method of treating tumor resistant to herceptin or paclitaxel using foxm1 inhibitors and detecting same |
| 06/06/2013 | US20130142779 Treatment of Hi-Virus infections with oxidised blood proteins |
| 06/06/2013 | US20130142778 Compositions for inhibiting gene expression and uses thereof |
| 06/06/2013 | US20130142777 Botulinum toxin treatments of depression |
| 06/06/2013 | US20130142776 Botulinum toxin treatments of depression |
| 06/06/2013 | US20130142775 Therapeutic apyrase constructs, apyrase agents, and production methods |
| 06/06/2013 | US20130142764 Methods and compositions for treating brain diseases |
| 06/06/2013 | US20130142760 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
| 06/06/2013 | US20130142756 Methods of improving central nervous system functioning |
| 06/06/2013 | US20130142755 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject |
| 06/06/2013 | US20130142754 Hepatitis C Virus Inhibitors |
| 06/06/2013 | DE102012008730A1 Oral composition, useful e.g. as dietary supplement, comprises monounsaturated fatty acids comprising oleic acid e.g. oleic acid-((Z)-9-octadecenoic acid) in combination with peptides consisting of specific amino acids and/or antioxidant |
| 06/06/2013 | CA2857747A1 Treatment of b cell lymphomas |
| 06/06/2013 | CA2857545A1 Mesenchymal stromal cells and uses related thereto |
| 06/06/2013 | CA2857539A1 Bacteriophage gene 3 protein compositions and use as amyloid binding agents |
| 06/06/2013 | CA2857502A1 Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same |
| 06/06/2013 | CA2857487A1 Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| 06/06/2013 | CA2857307A1 Methods and systems for protein refolding |
| 06/06/2013 | CA2857287A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | CA2857168A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | CA2857019A1 Novel enhanced selectin antagonists |
| 06/06/2013 | CA2856967A1 Therapeutic agents comprising insulin amino acid sequences |
| 06/06/2013 | CA2856480A1 Anticancer fusion protein |
| 06/06/2013 | CA2855223A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| 06/05/2013 | EP2599820A1 Collagen powder and/or collagen-derived powder, and production method for same |
| 06/05/2013 | EP2599788A1 Angiogenesis-inhibiting peptide and application thereof |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599502A2 Method for preparation of site-specific protein conjugates |
| 06/05/2013 | EP2599495A1 Activin-ActRIIa Antagonists and Uses for Treating or Preventing Breast Cancer |
| 06/05/2013 | EP2599494A1 PKC inhibitors for the treatment of inflammatory disease or disorder |
| 06/05/2013 | EP2599493A1 Antimicrobial activity enhancing agent |
| 06/05/2013 | EP2599476A1 Treatment of bladder dysfunction using liposomal botulinum toxin |
| 06/05/2013 | EP2598652A2 Assays for detection of glycosaminoglycans |
| 06/05/2013 | EP2598642A1 Polypeptides for use in the deconstruction of cellulose |
| 06/05/2013 | EP2598519A1 Anti-viral agent |
| 06/05/2013 | EP2598517A1 Modulators of protease activated receptors |
| 06/05/2013 | EP2598171A2 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 06/05/2013 | EP2598170A2 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 06/05/2013 | EP2598162A1 Method for generating thrombin |
| 06/05/2013 | EP2598161A2 Glp-1 receptor agonist compounds having stabilized regions |
| 06/05/2013 | EP2598160A2 Stabilization of fsh |
| 06/05/2013 | EP2598159A1 Inhibition of cyp3a drug metabolism |
| 06/05/2013 | EP2598158A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
| 06/05/2013 | EP2598157A1 Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion |
| 06/05/2013 | EP2598153A1 Synthetic synovial fluid compositions and methods for making the same |
| 06/05/2013 | EP2598117A2 Preservative free bimatoprost solutions |
| 06/05/2013 | CN1809632B Perivascular mesenchymal precursor cells |
| 06/05/2013 | CN103140588A Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields |
| 06/05/2013 | CN103140499A A novel conjugate of granulocyte colony-stimulating factor (g-csf) with polyethylene glycol |
| 06/05/2013 | CN103140236A Growth hormone polypeptides and methods of making and using same |
| 06/05/2013 | CN103140235A Method for predicting a therapy response in subjects with multiple sclerosis |
| 06/05/2013 | CN103140234A Methods for treatment of nephrotic syndrome and related conditions |
| 06/05/2013 | CN103140233A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 06/05/2013 | CN103140232A Enteral nutrient |
| 06/05/2013 | CN103140231A Skin collagen production-promoting agent |
| 06/05/2013 | CN103131714A Preparation method for nacre protein N16 and application of nacre protein N16 in preparation of drugs for prevention and treatment of orthopedic diseases |
| 06/05/2013 | CN103131713A Interest protein preparation method and purpose thereof |
| 06/05/2013 | CN103131687A Polyethylene glycol covalent modification lysostaphin and prepared method and application thereof |
| 06/05/2013 | CN103131686A Type two peptidoglycan recognition protein and preparation method and application thereof |
| 06/05/2013 | CN103131195A Matsutake active extractives and preparation method and application thereof |
| 06/05/2013 | CN103130898A TAT-LBD-PEP fusion protein and application of TAT-LBD-PEP fusion protein in treatment of central nervous system lesion |
| 06/05/2013 | CN103130881A Novel drug resistant gene of Klebsiella pneumoniae |
| 06/05/2013 | CN103130875A Method for extracting polymyxin B from fermentation broth |
| 06/05/2013 | CN103127527A Treatment of diabetes mellitus by taking insulin PEGylation derivative as active component |
| 06/05/2013 | CN103127514A Medicine sustained-release suppository capable of internal injection |
| 06/05/2013 | CN103127511A Novel drug composition for curing hepatitis c virus |
| 06/05/2013 | CN103127502A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 06/05/2013 | CN103127494A Nerve regeneration biogum and preparation method and application thereof |
| 06/05/2013 | CN103127493A Purpose of polypeptide Cbf-K16 anti-tumor drugs |
| 06/05/2013 | CN103127492A Anti-hepatitis C virus protein and application thereof |
| 06/05/2013 | CN103127491A Novel application of octreotide acetate in preparation of drug for treating short bowel syndrome |
| 06/05/2013 | CN103127490A Medicinal composition for treating vulvovaginal candidiasis |
| 06/05/2013 | CN103127489A Astragali-medlar antimicrobial peptide capsule and preparation process thereof |
| 06/05/2013 | CN103127316A Manufacturing method of earthworm medicinal liquor |
| 06/05/2013 | CN103127304A Composition for enhancing immunity and preparation process of composition |
| 06/05/2013 | CN103126999A Thymalfasin chitosan / beta-cyclodextrin composite microsphere drug delivery system and preparation method |
| 06/05/2013 | CN103126917A Bionic gynecologic care solution and its preparation method |
| 06/05/2013 | CN102559671B Recombinant stichopus japonicus lysozyme C-terminal polypeptide and preparation method and application thereof |
| 06/05/2013 | CN102416168B Aerosol inhalant containing interferon alpha and ambroxol |
| 06/05/2013 | CN102416167B Aerosol inhalant containing interferon alpha and terbutaline sulfate |
| 06/05/2013 | CN102416001B Octreotide acetate freeze-dried powder injection for injection and preparation method thereof |
| 06/05/2013 | CN102358753B Trypsin inhibitor active fragment derivative, and preparation method and application thereof |
| 06/05/2013 | CN102349995B Broad-spectrum antiviral medicament as well as preparation method and application thereof |
| 06/05/2013 | CN102342920B Pharmaceutical composition containing alarelin acetate and preparation method thereof |
| 06/05/2013 | CN102309764B Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 06/05/2013 | CN102227208B Drug or dermatological composition containing avocado peptide extract for treating and preventing pruritus |
| 06/05/2013 | CN102219847B Defensin mNP-1 and applications thereof in preparing anti-influenza virus drugs |
| 06/05/2013 | CN102178936B Methods for preparing collagen oleostock and moistening eyedrops |
| 06/05/2013 | CN102120760B Antibacterial peptide derived from phage and application thereof |
| 06/05/2013 | CN102100913B Target spot and medicine for treating cerebral injury |